Back

Zoar Limited files Form F-4 for Impact Biomedical business combination

Verifying
  • Zoar Limited filed a Form F-4 for its proposed combination with Impact Biomedical and Zoar Labs.
  • September 10, 2026, was the filing date for the registration statement with the SEC.
  • Closing requires SEC effectiveness, Impact stockholder approval, NYSE American listing approval, and other conditions.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.